B
Bpifrance Portfolio holdings
AUM
$2.09B
This Quarter Return
+0.97%
1 Year Return
-46.97%
3 Year Return
-14.84%
5 Year Return
-4.77%
10 Year Return
–
AUM
$3.96B
AUM Growth
+$3.96B
(+618%)
Cap. Flow
+$3.41B
Cap. Flow
% of AUM
86.04%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
7
New
2
Increased
–
Reduced
1
Closed
–
Top Buys
| 1 |
Stellantis
STLA
|
$3.41B |
| 2 |
CRISPR Therapeutics
CRSP
|
$975K |
Top Sells
| 1 |
SQNS
Sequans Communications
SQNS
|
$477K |
Sector Composition
| 1 | Consumer Discretionary | 86.03% |
| 2 | Materials | 6.08% |
| 3 | Energy | 4.76% |
| 4 | Communication Services | 2.38% |
| 5 | Technology | 0.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Stellantis
STLA
$27.8B
| $3.41B | 86.03% | +192,703,907 | New | +$3.41B |
|
2
Constellium
CSTM
$2.02B
| $241M | 6.08% | 16,393,903 | – | – |
|
3
TechnipFMC
FTI
$15.1B
| $189M | 4.76% | 24,688,691 | – | – |
|
4
Criteo
CRTO
$1.3B
| $94.4M | 2.38% | 2,718,752 | – | – |
|
|
SQNS
5
Sequans Communications
SQNS
$129M
| $19.9M | 0.5% | 3,300,018 -78,945 | -2% | -$477K |
|
|
CLLS
6
Cellectis
CLLS
$258M
| $8.6M | 0.22% | 425,726 | – | – |
|
|
7
CRISPR Therapeutics
CRSP
$4.71B
| $975K | 0.02% | +8,000 | New | +$975K |
|